Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Jacobio Pharma Announces 2024 Annual Results 2025-03-19 21:42
CARsgen Announced 2024 Annual Results 2025-03-19 08:15
A chronographic analysis of MSC's rollercoasting journey 2025-03-18 20:00
Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension 2025-03-18 16:00
TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025 2025-03-18 06:00
Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets 2025-03-17 21:00
NEXTBIOMEDICAL, Fast Resorbable Microsphere 'Nexsphere-F' : Clinical Study Results on 155 Patients Published in the JVIR 2025-03-17 21:00
WuXi AppTec Revenue and Profit Achieved Steady QoQ Growth in 2024, Meeting Full-year Guidance; Q4 Revenue and Profit Both Reached Record Highs 2025-03-17 20:19
Chance Pharma Secures New Funding to Accelerate Development of Innovative Inhalation Therapies 2025-03-17 18:00
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer 2025-03-17 11:49
Accropeutics Secured $12 Million in Series B Plus Financing 2025-03-14 16:23
Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation 2025-03-13 21:00
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025 2025-03-13 13:54
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors 2025-03-13 13:17
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy 2025-03-13 07:30
Caliway's CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal 2025-03-12 14:29
WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs 2025-03-11 21:20
WuXi Biologics Included in S&P Global Sustainability Yearbook 2025 2025-03-11 11:18
Harbour BioMed Appoints Dr. Ian Y. Liu as Global Head of Legal 2025-03-11 08:00
Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer 2025-03-11 08:00
1 28 29 30 31 32 262